{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:30:23Z","timestamp":1790731823532,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773094"],"award-info":[{"award-number":["81773094"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672500"],"award-info":[{"award-number":["81672500"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81272779"],"award-info":[{"award-number":["81272779"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472363"],"award-info":[{"award-number":["81472363"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402301"],"award-info":[{"award-number":["81402301"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402408"],"award-info":[{"award-number":["81402408"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372667"],"award-info":[{"award-number":["81372667"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572423"],"award-info":[{"award-number":["81572423"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.bbrc.2018.11.103","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T02:03:21Z","timestamp":1542679401000},"page":"9-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Valproic acid suppresses Warburg effect and tumor progression in neuroblastoma"],"prefix":"10.1016","volume":"508","author":[{"given":"Erhu","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liduan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangsong","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.11.103_bib1","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/S0959-8049(97)00324-9","article-title":"1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions. European Group for Blood and Marrow Transplant Registry Solid Tumour Working Party","volume":"33","author":"Philip","year":"1997","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.bbrc.2018.11.103_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/carcin\/bgt480","article-title":"Cancer as a metabolic disease: implications for novel therapeutics","volume":"35","author":"Seyfried","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrc.2018.11.103_bib3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2018.11.103_bib4","doi-asserted-by":"crossref","first-page":"10351","DOI":"10.1158\/0008-5472.CAN-10-0740","article-title":"Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1 alpha","volume":"70","author":"Qing","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2018.11.103_bib5","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2018.11.103_bib6","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1182\/blood-2013-12-546283","article-title":"Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients","volume":"123","author":"Tassara","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2018.11.103_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2007.10.006","article-title":"Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells","volume":"259","author":"Fortunati","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2018.11.103_bib8","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3892\/ol.2016.4880","article-title":"Valproic acid induces autophagy by suppressing the Akt\/mTOR pathway in human prostate cancer cells","volume":"12","author":"Xia","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbrc.2018.11.103_bib9","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1442-2042.2007.01823.x","article-title":"Chronic administration of valproic acid inhibits PC3 cell growth by suppressing tumor angiogenesis in\u00a0vivo","volume":"14","author":"Gao","year":"2007","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.bbrc.2018.11.103_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00432-015-2020-4","article-title":"Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4","volume":"142","author":"Lan","year":"2016","journal-title":"J.\u00a0Canc. Res. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2018.11.103_bib11","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1038\/onc.2015.422","article-title":"CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression","volume":"35","author":"Zhao","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2018.11.103_bib12","first-page":"1098","article-title":"Effects of 2-deoxyglucose on carbohydrate metabolism: review of the literature and studies in the rat","volume":"11","author":"Brown","year":"1962","journal-title":"Metabolism"},{"key":"10.1016\/j.bbrc.2018.11.103_bib13","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/emboj\/17.11.3005","article-title":"HIF-1 alpha is required for solid tumor formation and embryonic vascularization","volume":"17","author":"Ryan","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2018.11.103_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2018.11.103_bib15","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1128\/MCB.00440-07","article-title":"Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1","volume":"27","author":"Kim","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2018.11.103_bib16","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nrc2718","article-title":"p53 and E2f: partners in life and death","volume":"9","author":"Polager","year":"2009","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.bbrc.2018.11.103_bib17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0092-8674(86)90386-7","article-title":"Identification of a cellular transcription factor involved in E1A trans-activation","volume":"45","author":"Kovesdi","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2018.11.103_bib18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nature02820","article-title":"Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control","volume":"430","author":"Hernando","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2018.11.103_bib19","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/emmm.201000089","article-title":"Cycling through metabolism","volume":"2","author":"Aguilar","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbrc.2018.11.103_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1172\/JCI81542","article-title":"E2F1 mediates sustained lipogenesis and contributes to hepatic steatosis","volume":"126","author":"Denechaud","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2018.11.103_bib21","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/ncb2309","article-title":"E2F transcription factor-1 regulates oxidative metabolism","volume":"13","author":"Blanchet","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2018.11.103_bib22","doi-asserted-by":"crossref","first-page":"84623","DOI":"10.18632\/oncotarget.13170","article-title":"PPARalpha, a predictor of patient survival in glioma, inhibits cell growth through the E2F1\/miR-19a feedback loop","volume":"7","author":"Shi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.11.103_bib23","doi-asserted-by":"crossref","first-page":"87623","DOI":"10.18632\/oncotarget.21007","article-title":"Disrupting glucose-6-phosphate isomerase fully suppresses the \u201cWarburg effect\u201d and activates OXPHOS with minimal impact on tumor growth except in hypoxia","volume":"8","author":"de Padua","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.11.103_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081630","article-title":"PGK1 drives hepatocellular carcinoma metastasis by enhancing metabolic process","volume":"18","author":"Xie","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2018.11.103_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10637-010-9551-y","article-title":"The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma","volume":"30","author":"Levy","year":"2012","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.bbrc.2018.11.103_bib26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000338492","article-title":"Influence of dichloroacetate (DCA) on lactate production and oxygen consumption in neuroblastoma cells: is DCA a suitable drug for neuroblastoma therapy?","volume":"29","author":"Niewisch","year":"2012","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbrc.2018.11.103_bib27","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/cen.13154","article-title":"A\u00a0phase II trial of valproic acid in patients with advanced, radioiodine-resistant thyroid cancers of follicular cell origin","volume":"86","author":"Nilubol","year":"2017","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bbrc.2018.11.103_bib28","first-page":"5187","article-title":"Effects of valproic acid in combination with S-1 on advanced pancreatobiliary tract cancers: clinical study phases I\/II","volume":"34","author":"Iwahashi","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbrc.2018.11.103_bib29","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2015.04.038","article-title":"A\u00a0phase 2 study of concurrent radiation therapy, temozolomide, and the histone deacetylase inhibitor valproic acid for patients with glioblastoma","volume":"92","author":"Krauze","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbrc.2018.11.103_bib30","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1007\/s11033-014-3330-3","article-title":"Valproic acid inhibits the proliferation of SHSY5Y neuroblastoma cancer cells by downregulating URG4\/URGCP and CCND1 gene expression","volume":"41","author":"Dodurga","year":"2014","journal-title":"Mol. Biol. Rep."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18325270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18325270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:32:42Z","timestamp":1757763162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18325270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0006291X18325270"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.11.103","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid suppresses Warburg effect and tumor progression in neuroblastoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.11.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}